Header cover image
  • Investing Ideas
  • /
  • Chinese Pharmaceuticals & Biotech Undervalued based on future growth

Chinese Pharmaceuticals & Biotech Undervalued based on future growth

Results

2

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥18.3b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

CN¥11.31

7D

2.2%

1Y

-8.0%

Zhejiang Garden BiopharmaceuticalLtd

Market Cap: CN¥7.5b

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CN¥13.88

7D

-5.6%

1Y

18.2%